Managers / Q1 2026
Patient Capital Management, LLC
CIK 0001854794 · ONE SOUTH STREET, SUITE 2101, BALTIMORE, MD, 21202 · 410-454-3130
Reported Value
$2.7B
Q1 2026
Positions
40
Filings on Record
18
2019–present window
Filed
May 14, 2026
original filing
Summary
Patient Capital Management, Llc reported $2.7B in U.S.-listed holdings across 40 positions for Q1 2026.
Its largest position, Royalty Pharma, represents 6.4% of the portfolio.
Compared with Q4 2025, the fund opened 4 new positions and exited 4.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 71.8% · $2.0B
- Other · 20.0% · $548M
- MLP · 4.3% · $118M
- ETP · 2.3% · $64M
- ADR · 1.5% · $41M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q1 2026
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.7B | 40 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $2.6B | 40 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.5B | 41 | Oct 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $2.2B | 40 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.9B | 39 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.2B | 43 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $2.0B | 41 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.9B | 40 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.1B | 42 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.9B | 43 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.7B | 42 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.8B | 44 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $224M | 42 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $206.0B | 43 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $200M | 42 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $226M | 42 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $295M | 45 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $347M | 43 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.